vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and PRA GROUP INC (PRAA). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $333.4M, roughly 1.5× PRA GROUP INC). PRA GROUP INC runs the higher net margin — 17.0% vs 6.8%, a 10.1% gap on every dollar of revenue. On growth, PRA GROUP INC posted the faster year-over-year revenue change (13.7% vs -1.7%). Over the past eight quarters, PRA GROUP INC's revenue compounded faster (14.2% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
PRA Group, Inc. is a publicly traded debt buyer and debt collection company based in Norfolk, Virginia. The company buys delinquent consumer debt from credit card issuers and other financial institutions at a discount and pursues collection of the full debt owed. Founded in 1996, PRA Group employs more than 3200 people in 18 countries.
MD vs PRAA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $333.4M |
| Net Profit | $33.7M | $56.5M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 37.7% |
| Net Margin | 6.8% | 17.0% |
| Revenue YoY | -1.7% | 13.7% |
| Net Profit YoY | 10.5% | 206.3% |
| EPS (diluted) | $0.40 | $1.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $333.4M | ||
| Q3 25 | $492.9M | $311.1M | ||
| Q2 25 | $468.8M | $287.7M | ||
| Q1 25 | $458.4M | $269.6M | ||
| Q4 24 | $502.4M | $293.2M | ||
| Q3 24 | $511.2M | $281.5M | ||
| Q2 24 | $504.3M | $284.2M | ||
| Q1 24 | $495.1M | $255.6M |
| Q4 25 | $33.7M | $56.5M | ||
| Q3 25 | $71.7M | $-407.7M | ||
| Q2 25 | $39.3M | $42.4M | ||
| Q1 25 | $20.7M | $3.7M | ||
| Q4 24 | $30.5M | $18.5M | ||
| Q3 24 | $19.4M | $27.2M | ||
| Q2 24 | $-153.0M | $21.5M | ||
| Q1 24 | $4.0M | $3.5M |
| Q4 25 | 9.9% | 37.7% | ||
| Q3 25 | 13.8% | -101.4% | ||
| Q2 25 | 12.8% | 29.6% | ||
| Q1 25 | 7.0% | 27.7% | ||
| Q4 24 | 7.8% | 32.1% | ||
| Q3 24 | 6.6% | 32.0% | ||
| Q2 24 | -31.3% | 31.4% | ||
| Q1 24 | 3.2% | 26.0% |
| Q4 25 | 6.8% | 17.0% | ||
| Q3 25 | 14.5% | -131.0% | ||
| Q2 25 | 8.4% | 14.7% | ||
| Q1 25 | 4.5% | 1.4% | ||
| Q4 24 | 6.1% | 6.3% | ||
| Q3 24 | 3.8% | 9.6% | ||
| Q2 24 | -30.3% | 7.6% | ||
| Q1 24 | 0.8% | 1.4% |
| Q4 25 | $0.40 | $1.47 | ||
| Q3 25 | $0.84 | $-10.43 | ||
| Q2 25 | $0.46 | $1.08 | ||
| Q1 25 | $0.24 | $0.09 | ||
| Q4 24 | $0.37 | $0.47 | ||
| Q3 24 | $0.23 | $0.69 | ||
| Q2 24 | $-1.84 | $0.54 | ||
| Q1 24 | $0.05 | $0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $104.4M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $979.9M |
| Total Assets | $2.2B | $5.1B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $104.4M | ||
| Q3 25 | $340.1M | $107.5M | ||
| Q2 25 | $224.7M | $131.6M | ||
| Q1 25 | $99.0M | $128.7M | ||
| Q4 24 | $229.9M | $105.9M | ||
| Q3 24 | $103.8M | $141.1M | ||
| Q2 24 | $19.4M | $118.9M | ||
| Q1 24 | $8.0M | $108.1M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $979.9M | ||
| Q3 25 | $890.7M | $928.5M | ||
| Q2 25 | $833.8M | $1.3B | ||
| Q1 25 | $789.2M | $1.2B | ||
| Q4 24 | $764.9M | $1.1B | ||
| Q3 24 | $732.5M | $1.2B | ||
| Q2 24 | $706.5M | $1.1B | ||
| Q1 24 | $856.2M | $1.1B |
| Q4 25 | $2.2B | $5.1B | ||
| Q3 25 | $2.2B | $5.0B | ||
| Q2 25 | $2.1B | $5.4B | ||
| Q1 25 | $2.0B | $5.1B | ||
| Q4 24 | $2.2B | $4.9B | ||
| Q3 24 | $2.1B | $4.9B | ||
| Q2 24 | $2.0B | $4.7B | ||
| Q1 24 | $2.2B | $4.5B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $-85.5M |
| Free Cash FlowOCF − Capex | — | $-90.4M |
| FCF MarginFCF / Revenue | — | -27.1% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | 3.39× | -1.51× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-169.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $-85.5M | ||
| Q3 25 | $137.3M | $-10.1M | ||
| Q2 25 | $137.2M | $-12.9M | ||
| Q1 25 | $-117.5M | $-52.6M | ||
| Q4 24 | $133.0M | $-94.6M | ||
| Q3 24 | $91.8M | $-35.0M | ||
| Q2 24 | $107.0M | $-29.5M | ||
| Q1 24 | $-125.2M | $-73.0M |
| Q4 25 | — | $-90.4M | ||
| Q3 25 | — | $-11.3M | ||
| Q2 25 | — | $-14.2M | ||
| Q1 25 | — | $-53.5M | ||
| Q4 24 | — | $-98.6M | ||
| Q3 24 | — | $-36.1M | ||
| Q2 24 | — | $-30.8M | ||
| Q1 24 | — | $-73.5M |
| Q4 25 | — | -27.1% | ||
| Q3 25 | — | -3.6% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -19.8% | ||
| Q4 24 | — | -33.6% | ||
| Q3 24 | — | -12.8% | ||
| Q2 24 | — | -10.8% | ||
| Q1 24 | — | -28.8% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 0.2% |
| Q4 25 | 3.39× | -1.51× | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | -0.30× | ||
| Q1 25 | -5.66× | -14.37× | ||
| Q4 24 | 4.36× | -5.13× | ||
| Q3 24 | 4.72× | -1.29× | ||
| Q2 24 | — | -1.37× | ||
| Q1 24 | -31.03× | -21.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
PRAA
| GB | $170.1M | 51% |
| Other | $163.3M | 49% |
